Canadian Respirologists’ Experience with Lymphangioleiomyomatosis

BACKGROUND: Lymphangioleiomyomatosis (LAM) is a rare pulmonary disease occurring primarily in women. A literature review of LAM in Canada found sporadic mention of LAM in case reports or within lung transplant studies. The LAM Foundation, a patient support and research funding organization, lists 23...

Full description

Saved in:
Bibliographic Details
Main Authors: Stacey M Pollock-BarZiv, Marsha M Cohen, Heather Maclean, Gregory P Downey
Format: Article
Language:English
Published: Wiley 2002-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2002/721852
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND: Lymphangioleiomyomatosis (LAM) is a rare pulmonary disease occurring primarily in women. A literature review of LAM in Canada found sporadic mention of LAM in case reports or within lung transplant studies. The LAM Foundation, a patient support and research funding organization, lists 23 Canadian patients in its database. The present study was designed to assess the scope of LAM across Canada and to identify potential patients for further evaluation. OBJECTIVES: To ascertain Canadian respirologists’ experience with patients with LAM (current and historical), lung transplantation (single or bilateral) and deaths due to LAM, and awareness of the LAM Foundation.
ISSN:1198-2241